首页> 外文期刊>Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer >A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6
【24h】

A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6

机译:一个单核苷酸变异微rna - 1269 A促进的发生和过程肝细胞癌的目标致癌基因SPATS2L和LRP6

获取原文
获取原文并翻译 | 示例
           

摘要

Summary Hepatocellular carcinoma (HCC) is one of the malignant and lethal cancers. Single nucleotide polymorphisms (SNPs) in microRNAs(miRNAs) can affect the expression and target identification of miRNAs and lead to the formation of malignant tumors. However, little is known about whether microRNA-1269a (miR-1269a) SNPs affect the susceptibility and progression of HCC or their specific mechanism. The association between microRNA-1269a rs73239138 and the susceptibility to HCC was verified by MassARRAY assay in a large case-control sample. The effect of miR-1269a and the variant on the proliferation and apoptosis of HCC cells was examined by flow cytometry (FCM), CCK8 assay and Western blot. The target of miR-1269a was identified by bioinformatics analysis and qRT-PCR and its role on cell proliferative capacity was examined by CCK8 assay. The expression level of miR-1269a was analyzed by qRT-PCR in HCC cells transfected with wild or variant type pre-miR-1269a plasmid.MiR-1269a produced a tumor suppressor effect by inhibiting cell proliferation and inducing apoptosis of human HCC cells, possibly via inhibiting the expression of its target genes SPATS2L and LRP6 , which were tumor promoters. While, rs73239138 (G A) in miR-1269a reduced the anticancer effect of miR-1269a possibly by attenuating its total amount in HCC cells or its target recognition, reduce its inhibition on target genes and promoted the susceptibility to HCC. Our findings for the first time proved that miR-1269a SNP plays a role in the occurrence and process of HCC and the relevant mechanism, in accompany with the discovery of the novel target genes of miR-1269a .
机译:摘要肝细胞癌(HCC)是其中之一恶性和致命的癌症。核苷酸多态性(snp)小分子核糖核酸(microrna)会影响表达和目标识别的microrna并导致的恶性肿瘤的形成。知道是否微rna - 1269 a (mir - 1269 - a)单核苷酸多态性影响的易感性和进展肝细胞癌或其具体机制。微rna - 1269 a rs73239138和之间对肝癌被MassARRAY验证试验在一个大样本病例对照。mir - 1269 a和扩散的变体和流了肝癌细胞的凋亡血细胞计数(FCM) CCK8试验和免疫印迹。mir - 1269 a的目标被确定生物信息学分析和存在及其作用在细胞增殖能力进行检测CCK8化验。分析了存在在肝癌细胞转染野生或变体类型pre - mir - 1269 a质粒。通过抑制细胞增殖和效果诱导人肝癌细胞凋亡,可能是通过抑制靶基因的表达SPATS2L LRP6,肿瘤促进剂。同时,rs73239138 (G比;mir - 1269可能的抗癌效果衰减在肝癌细胞或其总量目标识别,减少其抑制目标基因和促进了易感性肝细胞癌。mir - 1269 a SNP在发生过程中发挥作用肝癌的过程和相关机制,伴随着小说的探索目标mir - 1269 a的基因。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号